Aripiprazole for neuroleptic induced hyperprolactinaemia

Venkata Kolli; Durga P. Bestha; Vishal Madaan; Seenaiah Byreddy

doi:10.1002/14651858.CD010786

Aripiprazole for neuroleptic induced hyperprolactinaemia

Venkata Kolli, Durga P. Bestha, Vishal Madaan, Seenaiah Byreddy

Research output: Contribution to journal › Article › peer-review

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness of the addition of aripiprazole, an atypical antipsychotic, in the treatment of antipsychotic induced hyperprolactinaemia.

Original language	English (US)
Article number	CD010786
Journal	Cochrane Database of Systematic Reviews
Volume	2013
Issue number	10
DOIs	https://doi.org/10.1002/14651858.CD010786
State	Published - Oct 16 2013
Externally published	Yes

All Science Journal Classification (ASJC) codes

Pharmacology (medical)

Access to Document

10.1002/14651858.CD010786

Fingerprint Dive into the research topics of 'Aripiprazole for neuroleptic induced hyperprolactinaemia'. Together they form a unique fingerprint.

Cite this

@article{d5a9417705c2431b8053a6836619fb8b,

title = "Aripiprazole for neuroleptic induced hyperprolactinaemia",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness of the addition of aripiprazole, an atypical antipsychotic, in the treatment of antipsychotic induced hyperprolactinaemia.",

author = "Venkata Kolli and Bestha, {Durga P.} and Vishal Madaan and Seenaiah Byreddy",

year = "2013",

month = oct,

day = "16",

doi = "10.1002/14651858.CD010786",

language = "English (US)",

volume = "2013",

journal = "Cochrane Database of Systematic Reviews",

issn = "1361-6137",

publisher = "John Wiley and Sons Ltd",

number = "10",

}

TY - JOUR

T1 - Aripiprazole for neuroleptic induced hyperprolactinaemia

AU - Kolli, Venkata

AU - Bestha, Durga P.

AU - Madaan, Vishal

AU - Byreddy, Seenaiah

PY - 2013/10/16

Y1 - 2013/10/16

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness of the addition of aripiprazole, an atypical antipsychotic, in the treatment of antipsychotic induced hyperprolactinaemia.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness of the addition of aripiprazole, an atypical antipsychotic, in the treatment of antipsychotic induced hyperprolactinaemia.

UR - http://www.scopus.com/inward/record.url?scp=85040459881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040459881&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD010786

DO - 10.1002/14651858.CD010786

M3 - Article

AN - SCOPUS:85040459881

VL - 2013

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1361-6137

IS - 10

M1 - CD010786

ER -

Aripiprazole for neuroleptic induced hyperprolactinaemia

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this